Seattle Genetics (SGEN) PT Raised to 'Street High' $165 at Goldman Sachs; Padcev could be best-in-class
Tweet Send to a Friend
Goldman Sachs analyst Salveen Richter raised the price target on Seattle Genetics (NASDAQ: SGEN) to a 'Street High' $165.00 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
